Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.495 USD | -2.29% | -6.25% | -20.63% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.78M | Capitalization | 126M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -123M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 45.3 x |
P/E ratio 2024 * |
-1.04
x | P/E ratio 2025 * |
-0.95
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.45% |
Latest transcript on Adicet Bio, Inc.
1 day | -6.13% | ||
1 week | -2.55% | ||
Current month | +2.68% | ||
1 month | -27.14% | ||
3 months | -38.06% | ||
6 months | +33.04% | ||
Current year | -19.05% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.5 | -1.96% | 188 391 |
24-05-23 | 1.53 | -6.13% | 511,116 |
24-05-22 | 1.63 | +1.24% | 496,429 |
24-05-21 | 1.61 | -0.62% | 519,755 |
24-05-20 | 1.62 | +1.25% | 636,018 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.05% | 126M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+46.11% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ACET Stock